CLASS II Drug recall · Reported 21 May 2014 · FDA Enforcement Report

Saluta (reduced glutathione) Powder for Injection, 600 mg/vial recalled

Flawless Beauty is recalling Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, distributed nationwide in the US. The recall was initiated on 29 Apr 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015
Quantity recalledunknown

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1318-2014
FDA event ID
68158
Recalling firm
Flawless Beauty, Asbury Park, NJ
Classification
Class II
Status
Completed
Recall initiated
29 Apr 2014
FDA classified
13 May 2014
Reported
21 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Packaging Defects

Timeline

29 Apr 2014Recall initiated by company
13 May 2014Classified by FDA+14 days
21 May 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary, UPC 6920425209014

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

Which lots are affected?

Lot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 68158

This product is part of a recall event; the main page for the event is Tatiomax (reduced glutathione/hydrolyzed collagen) powder recalled.

More recalls from Flawless Beauty

All 18